18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Stopped Reason for termination was a combination of slow accrual in setting of austerity measures regarding resource allocation.

Conditions

• Hepatocellular Carcinoma

Interventions

• DRUG: F18-FDG
• DEVICE: MRI
• DEVICE: CT
• DRUG: F18-DCFPyL
• PROCEDURE: Tumor biopsy

Sponsor

National Cancer Institute (NCI)